Showing 145–160 of 186 resultsSorted by popularity
HGH 191AA (Somatropin) is recombinant human growth hormone with the exact 191-amino acid sequence produced by the pituitary. It directly triggers lipolysis and indirectly drives systemic IGF-1 elevation for full-scale tissue regeneration, muscle growth, and metabolic optimization.
Hexarelin is the most potent synthetic GHRP hexapeptide, acting as a high-affinity GHS-R1a agonist that produces the largest GH spike among all secretagogues. Uniquely, it also binds the CD36 receptor for cardioprotective signaling, positioning it as a dual-purpose tool for GH release and myocardial repair research.
HCG (Human Chorionic Gonadotropin) is a highly glycosylated glycoprotein hormone that mimics luteinizing hormone, binding Leydig cell receptors to stimulate testosterone production. Its 24-36 hour half-life provides sustained endocrine activation, rendering it essential for gonadal axis restoration research.
Glutathione operates via complex enzymatic and non-enzymatic redox pathways.
GHRP-6 Acetate is a first-generation synthetic hexapeptide that mimics the hunger hormone ghrelin, potently activating the GHSR-1a receptor to stimulate growth hormone release. It induces a pronounced orexigenic response, rendering it a valuable tool for appetite stimulation and GH secretagogue research.
GHRP-2 Acetate (Pralmorelin) is a second-generation synthetic hexapeptide that acts as a potent ghrelin receptor agonist, triggering reliable growth hormone release from pituitary somatotrophs. With higher GHSR-1a affinity than GHRP-6 and minimal appetite stimulation, it is ideal for evaluating GH pulsatility.
Glow is a highly advanced, tri-part combined-action peptide matrix engineered for extensive tissue remodeling.
GDF-8 Myostatin Propeptide is the recombinant N-terminal prodomain that binds and neutralizes mature myostatin with high specificity, preventing ActRIIB engagement and releasing satellite cell-mediated muscle growth. Overexpression models demonstrate up to 200% increase in skeletal muscle mass.
FOXO4-DRI is a pioneering D-Retro-Inverso senolytic peptide that disrupts the FOXO4-p53 interaction in senescent cells, releasing p53 to trigger BAX/BAK-mediated apoptosis. This selective elimination of zombie cells reduces the senescence-associated secretory phenotype for geroscience research.
Follistatin 344/315 is a systemic myostatin antagonist that binds GDF-8 and activin A with near-irreversible affinity, blocking SMAD2/3 signaling to unleash satellite cell proliferation and whole-body muscle hypertrophy. The FS-315 isoform circulates systemically for broad musculoskeletal remodeling.
CJC-1295 without DAC (Modified GRF 1-29) is a tetrasubstituted GHRH analog engineered to stimulate natural, pulsatile growth hormone secretion from the anterior pituitary. Its 30-minute half-life mimics physiological GH rhythms without pituitary receptor downregulation.
CJC-1295 without DAC + Ipamorelin is a cooperative GHRH/GHRP stack that amplifies natural growth hormone pulsatility. Modified GRF 1-29 stimulates the pituitary while Ipamorelin selectively triggers ghrelin receptor-mediated GH release without appetite stimulation or prolactin elevation.
CJC-1295 with DAC is a long-acting GHRH analog featuring a maleimidopropionyl Drug Affinity Complex that covalently binds serum albumin, extending its half-life to 6-8 days. It provides sustained, continuous stimulation of growth hormone and IGF-1 secretion for multi-day neuroendocrine research.
Botulinum Toxin is a high-molecular-weight SNARE inhibitor that blocks acetylcholine release via heavy-chain ganglioside binding and SNAP-25/synaptobrevin cleavage. Research applications include neurotransmitter exocytosis studies and neuronal silencing protocols. 100 IU per vial, HPLC verified.
The core protective mechanism relies entirely on the integrated 0.9% benzyl alcohol. >99% purity confirmed by HPLC analysis.
Adipotide FTPP is a targeted peptidomimetic that selectively binds prohibitin on white adipose vasculature, triggering mitochondrial apoptosis and eliminating fat tissue infrastructure. Unlike lipolytic agents that merely empty fat cells, Adipotide fundamentally destroys them.
End of content
End of content
No products in the cart.
